Rocket Pharmaceuticals Current Assets

Rocket Pharmaceuticals (RCKT) currently reports a current assets of $150M as of March 2026. That compares with $320M in the prior-year period — down 53.8% year over year. Use the charts on this page to explore Rocket Pharmaceuticals's current assets history and peer comparisons.

Rocket Pharmaceuticals's current assets decreased from $320M to $150M — a 53.8% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rocket Pharmaceuticals reported $150M in current assets as of March 2026. That compares with $320M in the prior-year period — down 53.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rocket Pharmaceuticals, and consider following RCKT for alerts when major investors trade the stock.

Rocket Pharmaceuticals is classified in the Healthcare sector. On current assets, it currently shows $150M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RCKT with unrelated industries.